Amylyx Pharmaceuticals appoints George Milne to the board, Joshua Cohen as co-CEO, and ratifies Deloitte & Touche as its auditor.
1 report, 1 independent
Updated Jun 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amylyx Pharmaceuticals appoints George Milne to the board, Joshua Cohen as co-CEO, and ratifies Deloitte & Touche as its auditor.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amylyx Pharmaceuticals
American biopharmaceutical company
Nothing else this week.
-
Joshua Cohen
researcher ORCID 0000-0003-1227-8416
Nothing else this week.
-
Deloitte & Touche LLP
Professional services network
Nothing else this week.